Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study.

van Cleef BA, Kluytmans JA, van Benthem BH, Haenen A, Monen J, Daniels-Haardt I, Jurke A, Friedrich AW.

PLoS One. 2012;7(8):e42787. doi: 10.1371/journal.pone.0042787. Epub 2012 Aug 3.

2.

Low incidence of livestock-associated methicillin-resistant Staphylococcus aureus bacteraemia in The Netherlands in 2009.

van Cleef BA, van Benthem BH, Haenen AP, Bosch T, Monen J, Kluytmans JA.

PLoS One. 2013 Aug 29;8(8):e73096. doi: 10.1371/journal.pone.0073096. eCollection 2013.

3.

Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital.

Jeyaratnam D, Edgeworth JD, French GL.

J Hosp Infect. 2006 Aug;63(4):365-73. Epub 2006 Jun 9.

PMID:
16765481
4.

Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009.

Wilson J, Guy R, Elgohari S, Sheridan E, Davies J, Lamagni T, Pearson A.

J Hosp Infect. 2011 Nov;79(3):211-7. doi: 10.1016/j.jhin.2011.05.013. Epub 2011 Jul 20.

PMID:
21764174
5.

Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.

Pearson A, Chronias A, Murray M.

J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i11-7. doi: 10.1093/jac/dkp260. Review.

PMID:
19675013
6.

[MRSA bloodstream infections according to the German obligation for notification - data and experience of the MDRO Network Rhine-Main, Germany, 2011].

Heudorf U, Mischler D, Bobyk D, Bornhofen B, Maiwald M, Merbs R, Mühlhaus R, Wendel L.

Gesundheitswesen. 2014 Jun;76(6):385-91. doi: 10.1055/s-0033-1349871. Epub 2013 Aug 16. German.

PMID:
23954986
7.

Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years.

Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G.

J Antimicrob Chemother. 2012 Apr;67(4):802-9. doi: 10.1093/jac/dkr561. Epub 2012 Jan 4. Review.

PMID:
22223229
8.
9.

All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's results.

Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker DN.

J Hosp Infect. 1999 Mar;41(3):173-9.

PMID:
10204119
10.

EUREGIO MRSA-net Twente/Münsterland--a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus.

Friedrich AW, Daniels-Haardt I, Köck R, Verhoeven F, Mellmann A, Harmsen D, van Gemert-Pijnen JE, Becker K, Hendrix MG.

Euro Surveill. 2008 Aug 28;13(35). pii: 18965.

11.

MRSA bacteraemia: North/South Study of MRSA in Ireland 1999.

Mc Donald P, Mitchell E, Johnson H, Rossney A, Humphreys H, Glynn G, Burd M, Doyle D, Mc Donnell R.

J Hosp Infect. 2002 Dec;52(4):288-91.

PMID:
12473474
12.

Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study.

Walker S, Peto TE, O'Connor L, Crook DW, Wyllie D.

PLoS One. 2008 Jun 11;3(6):e2378. doi: 10.1371/journal.pone.0002378.

13.

Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW.

Euro Surveill. 2010 Oct 14;15(41):19688. Review. Erratum in: Euro Surveill. 2010;15(42). pii: 19694.

14.

Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.

Rubio-Terrés C, Garau J, Grau S, Martinez-Martinez L; Cast of Resistance Study group.

Clin Microbiol Infect. 2010 Jun;16(6):722-8. doi: 10.1111/j.1469-0691.2009.02902.x. Epub 2009 Aug 27.

15.

UK Renal Registry 11th Annual Report (December 2008): Chapter 12 Epidemiology of Methicillin Resistant Staphylococcus aureus bacteraemia amongst patients receiving Renal Replacement Therapy in England in 2007.

Fluck R, Wilson J, Davies J, Blackburn R, O'Donoghue D, Tomson CR.

Nephron Clin Pract. 2009;111 Suppl 1:c247-56. doi: 10.1159/000210001. Epub 2009 Mar 26.

16.

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28.

PMID:
20511366
17.
18.

Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005.

Lamagni TL, Potz N, Powell D, Pebody R, Wilson J, Duckworth G.

J Hosp Infect. 2011 Jan;77(1):16-20. doi: 10.1016/j.jhin.2010.07.015. Epub 2010 Oct 28.

PMID:
21030112
19.

Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains.

Tacconelli E, Venkataraman L, De Girolami PC, DAgata EM.

J Antimicrob Chemother. 2004 Mar;53(3):474-9. Epub 2004 Feb 4.

PMID:
14762054
20.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565

Supplemental Content

Support Center